Selenium
A mineral supplement that may help mild thyroid eye disease, particularly in early stages.
Drug Class: Supportive Care
3 min read
Selenium is an essential mineral with antioxidant properties. It's studied for potential benefits in mild thyroid eye disease, particularly in early, active phases.
Key Takeaways
- Antioxidant mineral
- May help mild thyroid eye disease
- Best evidence for early, active disease
- Generally safe at recommended doses
- Not a substitute for medical treatment
Background
The EUGOGO trial showed selenium may improve quality of life and slow progression in mild thyroid eye disease, particularly in selenium-deficient regions. Benefit in selenium-replete areas is less certain.
Evidence
What It May Help
- Mild, active thyroid eye disease
- May improve quality of life
- May slow progression
- Best in early disease
What It Doesn't Replace
- Not for moderate to severe disease
- Not instead of steroids when needed
- Not for established, inactive disease
Dosing
- 100 mcg twice daily
- 200 mcg total daily
- For 6 months typically
- Do not extend beyond 6 months unless your clinician specifically recommends it and reviews your total selenium intake from diet and other supplements
Forms
- Sodium selenite
- Selenomethionine
- Available over the counter
- Various brands available
Safety
Generally Safe at Recommended Doses
- Upper limit: 400 mcg daily
- Don't exceed recommended dose
- Total intake matters-multivitamins, thyroid supplements, and "hair/nail" supplements may already contain selenium
Toxicity Signs (Overdose)
- Hair loss
- Nail changes
- GI upset
- Garlic breath odor
- Fatigue or irritability
- Nerve problems
Who Should Consider It
- Mild thyroid eye disease
- Active phase (early)
- Discussed with doctor
- As part of overall management
Who Should Avoid It
- Already getting enough selenium in diet
- Kidney disease (impaired excretion)
- Taking selenium from other supplements
With Other Treatments
- Can use with artificial tears
- Discuss with doctor before combining with other TED treatments
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice.
Sources:
- Bartalena L, et al. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol. 2021;185(4):G43-G67.
- Marcocci C, et al. Selenium and the course of mild Graves' orbitopathy. N Engl J Med. 2011;364(20):1920-1931.
- National Institutes of Health Office of Dietary Supplements. Selenium Fact Sheet for Health Professionals.
Was this article helpful?
